Similar articles

• Risk stratification in nonischemic dilated cardiomyopathy: Current perspectives.

  Okutucu S, Oto A. Okutucu S, et al. Cardiol J. 2010;17(3):219-29. Cardiol J. 2010. PMID: 20535711 Review.
• Occurrence of implantable defibrillator events in patients with syncope and nonischemic dilated cardiomyopathy.

  Russo AM, Verdino R, Schorr C, Nicholas M, Dias D, Hsia H, Callans D, Marchlinski FE. Russo AM, et al. Am J Cardiol. 2001 Dec 15;88(12):1444-6, A9. doi: 10.1016/s0002-9149(01)02133-6. Am J Cardiol. 2001. PMID: 11741573 No abstract available.
• Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator.

  Knight BP, Goyal R, Pelosi F, Flemming M, Horwood L, Morady F, Strickberger SA. Knight BP, et al. J Am Coll Cardiol. 1999 Jun;33(7):1964-70. doi: 10.1016/s0735-1097(99)00148-5. J Am Coll Cardiol. 1999. PMID: 10362200
• [Causes and prognosis of syncope in patients with primary dilated cardiomyopathy].

  Brembilla-Perrot B, Suty-Selton C, Beurrier D, Houriez P, Nippert M, Terrier de la Chaise A, Louis P, Claudon O, Blangy H, Juillière Y. Brembilla-Perrot B, et al. Arch Mal Coeur Vaiss. 2004 Dec;97(12):1200-5. Arch Mal Coeur Vaiss. 2004. PMID: 15669361 French.
• [Dilated cardiomyopathy and syncope: management].

  Brembilla-Perrot B. Brembilla-Perrot B. Arch Mal Coeur Vaiss. 2007 Sep;100(9):782-6. Arch Mal Coeur Vaiss. 2007. PMID: 18033007 Review. French.